Disorders of gastrointestinal motility are frequently seen in clinical practice. Apart from motility disorders, factors leading to lowered visceroperception thresholds are recognized as commonly ...
Gvoke VialDx is expected to be available in the third quarter of 2025. The Food and Drug Administration (FDA) has approved Gvoke VialDx ™ (glucagon) for intravenous use as a diagnostic aid during ...
Engineers at MIT and Caltech have demonstrated an ingestible sensor whose location can be monitored as it moves through the digestive tract, an advance that could help doctors more easily diagnose ...
First in the region to offer comprehensive procedures including Colonic and Antroduodenal Manometry Doha, Qatar: Sidra Medicine, a member of Qatar Foundation, has expanded its diagnostic capabilities ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback